Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Neptune Wellness Solutions Inc (NEPT) NPV

Sell:3.87 CAD Buy:4.08 CAD Change: 0.08 CAD (2.03%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
Sell:3.87 CAD
Buy:4.08 CAD
Change: 0.08 CAD (2.03%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
Sell:3.87 CAD
Buy:4.08 CAD
Change: 0.08 CAD (2.03%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Neptune Wellness Solutions Inc. is a Canada-based cannabinoids extraction company. The Company provides with cannabinoids extraction, formulation and turnkey packaging solutions. The Company is into the development of value-added and differentiated products for the Canadian and global cannabis markets. Neptune’s activities also include the development and commercialization of turnkey nutrition solutions and patented ingredients such as maxsimil, and of a variety of marine and seed oils.

Contact details

Address:
545 Prom du Centropolis Suite 100
LAVAL
H7T 0A3
Canada
Telephone:
+1 (450) 6872262
Website:
neptunecorp.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NEPT
ISIN:
CA64079L1058
Market cap:
357.79 million CAD
Shares in issue:
92.76 million
Sector:
Personal Products
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • John Moretz
    Chairman of the Board
  • Michael Cammarata
    Chief Executive Officer, Director
  • Mario Paradis
    Chief Financial Officer
  • Michel Timperio
    Senior Vice President of Sales - Global Sales
  • Stephen Lijoi
    Vice President - Operations
  • Brett DuBose
    Vice President of Sales, U.S. Region
  • Martin Landry
    Chief of Corporate Development and Strategy
  • Pierre Lemieux
    Chief Operating Officer of Acasti
  • Graham Wood
    Chief Scientific Officer
  • Jean-Daniel Belanger
    Corporate Secretary and Director - Corporate Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.